[Federal Register Volume 75, Number 162 (Monday, August 23, 2010)]
[Notices]
[Page 51827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20861]
[[Page 51827]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: September 15-17, 2010.
Time: September 15, 2010, 1:30 p.m. to 5:30 p.m.
Agenda: The Office of Biotechnology Activities (OBA) and NIH
Recombinant DNA Advisory Committee will review and discuss selected
human gene transfer protocols as well as related data management
activities. Please check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Executive Meeting Center, Rockville, MD 20852.
Time: September 16, 2010, 8 a.m. to 5:30 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols, have a discussion of
ethical considerations in review of pediatric protocols, and discuss
related data management activities. Please check the meeting agenda
at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more
information.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Executive Meeting Center, Rockville, MD 20852.
Time: September 17, 2010, 8 a.m. to 1 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols, have a discussion of
ethical considerations in review of pediatric protocols, and discuss
related data management activities. Please check the meeting agenda
at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more
information.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Executive Meeting Center, Rockville, MD 20852.
Contact Person: Chezelle George, Office of Biotechnology
Activities, Office of Science Policy/OD, National Institutes of
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892. 301-496-
9838. [email protected].
Information is also available on the Institute's/Center's home
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 17, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20861 Filed 8-20-10; 8:45 am]
BILLING CODE 4140-01-P